周期素依賴性激酶抑制因子2A(CDKN2A)重組蛋白
Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1
- 編號(hào)RPA794Ra01
- 物種Rattus norvegicus (Rat,大鼠)相同的名稱,不同的物種。
- 來(lái)源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位細(xì)胞核, 細(xì)胞質(zhì)
- 預(yù)測(cè)分子量20.3kDa
- 實(shí)際分子量21kDa(差異分析請(qǐng)參閱說(shuō)明書(shū))
- 片段與標(biāo)簽Ser3~Pro155 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)9.1
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請(qǐng)參見(jiàn)活性蛋白。 - 下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 1166 ¥ 2916¥ 5832¥ 17496¥ 43740
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
序列

用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Rattus norvegicus (Rat,大鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA794Ra01 | 周期素依賴性激酶抑制因子2A(CDKN2A)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA794Ra01 | 周期素依賴性激酶抑制因子2A(CDKN2A)多克隆抗體 | WB; ICC/IF |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Biochemical genetics | Comparison of Selected Protein Levels in Tumour and Surgical Margin in a Group of Patients with Oral Cavity Cancer[pubmed:28421310] |
European?Journal of Pharmaceutical?Sciences | Development of core-shell nanocarrier system for augmenting piperine cytotoxic activity against human brain cancer cell line[Pubmed:29597041] |
Clinical and Experimental Medicine | Senescence-associated miR-34a and miR-126 in middle-aged Indians with type 2 diabetes[Pubmed: 31732824] |
MOLECULAR AND CELLULAR BIOCHEMISTRY | Tumor suppressor genes are differentially regulated with dietary folate modulations in a rat model of hepatocellular carcinoma[Pubmed: 32974833] |